Treatment with the IGF1R inhibitor PPP reversed the cognitive improvement observed in AD mice with microglial Rack1 knockout in the MWM and NOR tests (Figure S12A–E, Supporting Information). The gene discussed is IGF1R; the disease is Alzheimer disease.